ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
4
views
0
references
Top references
cited by
9
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,078
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
A phase I/II study of HB-201, an arenavirus-based cancer immunotherapy, alone, or in combination with anti-PD-1 in patients with HPV16+ cancers
Author(s):
B Burman
,
J Niu
,
RS Leidner
,
D WANG
,
DL Richardson
,
C. Iacobucci
,
A Hwang
,
X. Qing
,
I Matushansky
,
D Zamarin
,
P Rouanet
,
E Rullier
,
B Lelong
,
T Powles
,
SH PARK
,
E Voog
,
C Caserta
,
BP Valderrama
,
H Gurney
,
S.H PARK
,
B. VALDERRAMA
,
H. Kalofonos
,
S. RADULOVIC
,
W Demey
,
A. Ullen
,
B.P. Valderrama
,
SH Park
Publication date:
2020
Journal:
Journal of Clinical Oncology
Read this article at
ScienceOpen
Publisher
PubMed
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Cancer Immunotherapy
Author and article information
Journal
PubMed ID::
33052757
DOI::
10.1200/JCO.2020.38.18_suppl.LBA1
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,078
Abstract Lb049: preliminary analysis of Immunogenicity of HB-201 and HB-202, an Arenavirus-based cancer Immunotherapy, in patients with advanced Hpv16-positive cancers
Authors:
K Katchar
,
M Schwendinger
,
D DaSilva
…
Diffuse high intensity PD-L1 staining in thymic epithelial tumors.
Authors:
Sukhmani K. Padda
,
Jonathan W Riess
,
Erich J Schwartz
…
Economic impact of first-line (1L) immunotherapies in advanced/metastatic non-small cell lung cancer (NSCLC): a systematic literature review (SLR) [abstract]
Authors:
G Sarri
,
A Freitag
,
P Kazmierska
…
See all similar
Cited by
9
Prognostic and Predictive Value of Tumor-Infiltrating Immune Cells in Urothelial Cancer of the Bladder
Authors:
Sandra van Wilpe
,
Eveline C. F. Gerretsen
,
Antoine G. van der Heijden
…
Targeted Molecular Therapeutics for Bladder Cancer—A New Option beyond the Mixed Fortunes of Immune Checkpoint Inhibitors?
Authors:
Olga Bednova
,
Jeffrey Leyton
Trial watch: intratumoral immunotherapy
Authors:
Juliette Humeau
,
Julie Le Naour
,
Lorenzo Galluzzi
…
See all cited by